MARKET

APGE

APGE

Apogee Therapeutics Inc
NASDAQ
134.57
-0.02
-0.01%
After Hours: 134.57 0 0.00% 16:10 08/18 EDT
OPEN
134.55
PREV CLOSE
134.59
HIGH
134.60
LOW
134.54
VOLUME
992.19K
TURNOVER
--
52 WEEK HIGH
134.88
52 WEEK LOW
35.39
MARKET CAP
10.19B
P/E (TTM)
-31.0198
1D
5D
1M
3M
1Y
5Y
1D
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
Seeking Alpha · 1d ago
Apogee Therapeutics downgraded to Neutral from Buy at BTIG
TipRanks · 1d ago
Weekly Report: what happened at APGE last week (0810-0814)?
Weekly Report · 1d ago
Apogee Therapeutics price target raised to $135 from $81 at Truist
TipRanks · 1d ago
Soros exits position in Salesforce, cuts Amazon stake
TipRanks · 2d ago
Soros adds American Electric Power, exits Salesforce, boosts Entergy stake, among Q2 trades
Seeking Alpha · 4d ago
Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)
TipRanks · 5d ago
Apogee Therapeutics Is Maintained at Hold by Truist Securities
Dow Jones · 5d ago
More
About APGE
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is advancing novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. APG777, the Company’s most advanced program, is being initially developed for the treatment of AD. With four validated targets in its portfolio, it is seeking to achieve efficacy and dosing through monotherapies and combinations of its novel antibodies. Its most advanced programs are APG777, APG990, APG333, and APG808. APG990 is an SQ extended half-life mAb that utilizes advanced antibody engineering to target OX40L. APG333 is a fully human mAb against thymic stromal lymphopoietin (TSLP). APG808 is an SQ extended half-life mAb targeting IL-4Ra. APG279 is for the dual inhibition of OX40L and IL-13.

Webull offers Apogee Therapeutics Inc stock information, including NASDAQ: APGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APGE stock methods without spending real money on the virtual paper trading platform.